Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
free shares are nice well done!
As long as I don't use the money I've set aside for my wife's heart transplant to speculate further with Halberd I should be okay...Riding free shares helps considerably as well...
That detects brain trauma, ours alleviates it. :) Perhaps Abbott has already eyeballed our company! :).
Agree. This isn't the old Halberd/Premier Biomedical. They now have proven inventions and funding and when the 'News' hits main stream if you don't already have your shares you will be out of luck.
I don’t believe it’s a scam…. Believe what you want but I’m invested because of their science. Plus, they now have a government contract (CRADA) in play. It’s in its early stages but progress is being made. Is it risky? Of course, but what OTC stock isn’t…
With that being said, when this runs up…. It’s going to run real hard and fast and I’m not going to miss this opportunity!
⤴️
Fool, I don't own any of this, but come back to see poor souls withering away on a company that was proven a scam long ago.
which one you own?
First it was the University of AZ, now its Mizzou. You know you can rent research labs there, and the Pink stock owner calls it a partnership, right? You can get a letter with them telling them you'll provide royalties later, and they'll sign a 'light partnership PR piece' for you, right, you know this right?
Halberd has been operating out of home offices, old ones at that, making fake pumper videos with terrible sets and actors, you've seen these right? I have.
From extra-corporeal blood cleanings, to nasal spray, to probably nuclear dog food this next quarter, they are all over the place. 10 years, and nothing.
SCAM.
If it's a scam, why would the University of Missouri sully its reputation by partnering with Halberd in the first place? And how could William Hartmann secure a CRADA contract for Military Active Duty and Veterans if they didn't have a plausible solution to PTSD or related systemic disorders? If this company was making false claims wouldn't that emerge during the vetting process initiated by the entities who agreed to work with them?
Bye bye fungi and bye bye brain trauma. Hello $$$$$$$$$$$$$$$ :)
"Could be difference between life and death". I wonder if Mr. Hartman means the patient or Halberd Corp?
$HALB Halberd requests a meeting with the CDC to review their successful eradication of all strains of antibiotic-resistant bacteria and fungi in 10 minutes or less vs up to seven days using conventional means. Could be difference between life and death.
9:19 AM · Apr 18, 2024
$HALB Halberd requests a meeting with the CDC to review their successful eradication of all strains of antibiotic-resistant bacteria and fungi in 10 minutes or less vs up to seven days using conventional means. Could be difference between life and death.
— Halberd Corporation (@HalberdC) April 18, 2024
Never, been a scam from day 1.
I've been watching this one for a while now. The thought of having a niche market for their patented nasal mist spray to combat depression is intriguing to say the least. But since this is, after all, a bulletin board stock I refuse to use the money I've set aside for my wife's heart transplant to buy shares of it. Instead, I've used my spare beer money to take out a small position in Halberd to see where it goes. Does anyone have even a vague idea when this all might come together--perhaps by Labor Day? Just curious...
ask=.0092
vol-284,000
Great news today! This sounds like a solid study they’ve put together. If this trial achieves what Halberd has been claiming it’s capable of this is going to be HUGE. Too many possible partnerships to name!
On another note, I remember Hartman releasing a PR back in 2022 or something talking about Extendalife where their extracorporeal therapy can target certain antigens tied directly to the aging process. Remember this? I was thinking maybe Hartman himself has been doing trials with this? He has to be closer to 90 if he went to college in ‘59. Maybe he’s a walking PR for their technology!?
Oscar Wilde I am sure they are working on the extracorporeal treatment at YSU as well. LDN+ and the nasal spray are the low hanging fruit that can be marketed much faster which is why they moved to the forefront. Getting a Government contract of the scope described is huge and should move everything along big time.👍🙏🤗🔥🔥🧨🧨💥💥
Where are you Crodin Health? This should be all over the 10 oc news.
Yes I saw that. Came out this morning I believe :)
Where did you see that good news?
Good news: Halberd's Patented Drug, LDN+, the Subject of a Limited Clinical Trial Under an Innovative Four-Company Cooperative Research and Development (CRADA) Contract.
Exactly. I invested here only because of the extracorporeal project. Then the nasal spray got pushed to the front.
I will say I didn’t appreciate Athena GTX’s CEO describing the extracorporeal treatment as a Sci-fi/Star Wars pie-in-the-sky idea during that interview. It’s proven capable of working and is still a large part of why I’m invested here. I wish Hartman would speak to any progress, or to its status in general, while we await news of progress from the nasal spray. A reminder to shareholders and potential investors that all our eggs aren’t in one basket would help rejuvenate some enthusiasm around this company’s potential.
Feel sorry for the guy's who bought back in the "Great HALB Pump of 2021" that are still holding.
I'm sure the bags are empty and the butts be hurtin.
So Athena gets a cut of the revenue for filing the government application. What does the government get for funding the research?
Doesn't LDN need FDA approval before approval of LDN+?
Glad to see you making $$ here flipping
Lock those shares up folks. Gives the MM less to work with. :)
I have had correspondence with him also. All my replies in " " . :)
Conflating shares awarded for spokes person with toxic financing?
I guess that is what that was???
Pretty sure we were just pointing out that there was compensation for that endorsement.
These guys. lol
What does Athena get in return?
Well, if they're not stupid (they're not) they get at least 50% of all revenue. As you know it is Athena who filed for the two government grants, a total of 6M. They will get it and because of that they guarantee all bills from MSU (nasal spray). Same with LDN+. I did some research and the road to FDA approval for LDN+ is very short. We're waiting for news about both. So far investing in $HALB has turned out very profitable. I took some profits when they "peaked", but now have more than ever, buying the dips.
How much does 333 million shares equate to? Wow!
What does Athena get in return?
Good to see you back Junkie
I've spoken with Mr Hartman and I believe he's sincerely driven to make Halberd's products a big success. I also have a Huge stash of shares, but not quite 3.5 million.
It's going to be HUGE $$$. 3.5 MIL HERE :)
1 million shares equals $8,500.00. Do you really think an $8,500.00 loan is toxic debt? Wow! I can't wait to hear about government contracts and advancement with the nasal spray at MSU.🤗👍🙏💥💥🧨🧨🔥🔥
(responsible mod: Bill Moynihan)
Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.
Halberd holds the exclusive rights to 4 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629, no. 8,865,733
Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University; Dr. Richard Carr and his team at Mississippi State University), is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 4 granted patents and 22 pending provisional/non-provisional (some PCT) patent applications.
2024: In close cooperation with partner (revenue sharing agreement in place) AthenaGTX, Halberd Corp is working on contracts from the military, to develop treatments to tackle Traumatic Brain Injury/TBI (patent pending nasal spray) and Post Traumatic Stress Syndrome/PTSD (patented Low-Dose-Naltrexone product).
CEO William Hartman: "The principal competitive Alzheimer's drug treatment available today eliminates 5-15% of Beta Amyloid after one month of treatment costing over $50,000 per year. Halberd's extracorporeal process eradicates 100% within just 10 minutes."
JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation (OTC PINK:HALB) is scheduled to meet with Center of Disease Control (CDC) representatives to discuss Halberd's incredible success in eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and Candida auris samples previously provided by the CDC.
JACKSON CENTER, PA / ACCESSWIRE / September 6, 2023 / Halberd Corporation's (OTC PINK:HALB) research at Mississippi State University (MSU) has shown significant reduction in two key markers of traumatic brain injury (TBI) in early testing of Halberd's patent-pending nasal spray to mitigate the effects of TBI. Anecdotal data in preliminary testing reveals a 20% reduction in Neuron Specific Enolase and a 50% reduction in the levels of Glial Fibrillary Acid Protein compared to the control group.
JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of submissions for government contracts seeking proposals for the detection and treatment of traumatic brain injury (TBI). The initial focus will be on accelerating and fine-tuning Halberd's proprietary nasal spray for suppressing the effects of traumatic brain injury (TBI).
JACKSON CENTER, PA / ACCESSWIRE / December 13, 2023 / Halberd Corporation (OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd's patented low dose naltrexone combo product(s) worldwide. The agreement also allows CrodenHealth.com right of first refusal regarding similar rights to future products in Halberd's development pipeline.
JACKSON CENTER, PA / ACCESSWIRE / January 10, 2024 / Halberd Corporation (OTC-PINK:HALB) is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa, (www.athenagtx.com). Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |